GLyPharma Therapeutic - Ownership and Business Overview

Life ScienceCompany

GLyPharma Therapeutic Ownership

Who owns GLyPharma Therapeutic?

GLyPharma Therapeutic is owned by Therachon AG. It was acquired on October 9, 2018.

GLyPharma Therapeutic Business Overview

Where is GLyPharma Therapeutic headquartered?

GLyPharma Therapeutic is headquartered in Montreal, Quebec.

What sector is GLyPharma Therapeutic in?

GLyPharma Therapeutic is a life science company.

When was GLyPharma Therapeutic founded?

GLyPharma Therapeutic was founded in 2012.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

GLyPharma Therapeutic, Inc.

1188 Union, Suite 504,
Montreal, Quebec H3B 0E5
Canada,
(514) 876-4220
www.glypharma.com

GLyPharma Therapeutic, Inc. is a pharmaceutical company specialized in the discovery and development of active peptides, FONDS de solidarité FTQ and CTI Life Sciences Fund. GLyPharma Therapeutic, Inc. was founded in 2012 and is based in Montreal, Quebec.


 Subscribe to unlock this and 206,758
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.